Efficacy of an Immune Modulator in Experimental Chlamydia trachomatis Infection of the Female Genital Tract
Objective. The aim of this study was to determine if vaginal application of the immune response modifier imiquimod (Aldara cream, 3M Pharmaceuticals, St Paul, Minn) would alter the course and/or outcome of female genital tract infection with a human isolate of Chlamydia trachomatis in a murine model...
Saved in:
Main Authors: | Joseph M. Lyons (Author), James I. Ito (Author), Servaas A. Morré (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2006-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of an Immune Modulator in Experimental <emph>Chlamydia trachomatis</emph> Infection of the Female Genital Tract
Published: (2006) -
Immune Pathogenesis of Asymptomatic Chlamydia trachomatis Infections in the Female Genital Tract
by: Steven S. Witkin
Published: (1995) -
The Influence of Vaginally Applied Imiquimod on the Course of Chlamydia trachomatis Serovar D Infection in a Murine Model
by: Joseph M. Lyons, et al.
Published: (2005) -
Persistent "Silent" Chlamydia trachomatis Female Genital Tract Infections
by: M. Askienazy-Elbhar, et al.
Published: (1999) -
The Influence of Vaginally Applied Imiquimod on the Course of Chlamydia trachomatis Serovar D Infection in a Murine Model
by: Servaas A. Morré, et al.
Published: (2005)